Centene Corporation Beats Q2 Earnings and Raises Full-Year Guidance

Centene Corporation reported a sharp increase in performance for the second quarter of 2026, with adjusted earnings per share exceeding consensus expectations by 48%. Following these results, company management raised its full-year financial guidance.

Investors attributed the growth to the company's Medicaid margin recovery and Affordable Care Act membership reset, both of which are tracking ahead of original projections. As a managed care organization with approximately 28 million at-risk enrollees, the company is benefiting from a broader U.S. trend toward government-funded, cost-controlled healthcare programs.

Hotchkis & Wiley identified the company as a leading performance contributor in its Q2 2026 investor letter. As of August 3, 2026, Centene shares closed at $63.76, bringing the company's market capitalization to $31.49 billion.